<DOC>
	<DOCNO>NCT01571063</DOCNO>
	<brief_summary>Test efficacy vitamin D improve non-alcoholic steatohepatitis regard biochemical histological parameter . - Trial medicinal product</brief_summary>
	<brief_title>Treatment Non-alcoholic Steatohepatitis ( NASH ) Patients With Vitamin D</brief_title>
	<detailed_description />
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Inclusion criterion : Patients 25OH vitamin D insufficiency Elevated alanine aminotransferase level Diagnosis definite possible steatohepatitis ( NASH ) Exclusion criterion : Cirrhosis , present liver disease NASH Serious diseases limit life expectancy , Breastfeeding pregnant woman Unhealthy alcohol consumption Drug abuse substitution therapy Use vitamin preparation within previous 6 month study Weight loss &gt; 5 % within 12 month study entry Newly diagnose Diabetes mellitus require medical treatment within 12 month study entry Use antiobesity drug Previous current hypercalcemia Chronic renal disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>